Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. Endpoints News Top biotech investor Peter Kolchinsky tees up a new SPAC 3 days after a $300M raise for radiopharmaceuticals play News Dec 9, 2020 Endpoints News RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and other similar diseases Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. Other family members and associates include Alexander Kolchinsky, Evelina Kolchinsky, Anna Kolchinsky, Joseph Kolchinsky and Joseph Kolchinsky. Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. The co-heads of the venture at RA are Josh Resnick and Andrew Levin, working with 9 other professionals. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The company hired hundreds of new employees and paid . Words cant bring Christina Aguilera down but frown lines can. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. She has a Masters in theological studies from Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. The RA Capital Nexus Fund closed at just over $300 million, they said in a statement. (LogOut/ Currently, Peter is married. (LogOut/ Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $38,029,167 and over the last 9 years he sold WVE stock worth over $58,095,632. All Rights Reserved. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. The foursome plans to open for guests in the late spring of 2010. In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. Your email address will not be published. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky usually trades in December, with the busiest year in 2022. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. In the last year at Solid Biosciences Inc, Peter Kolchinsky has sold an estimated value of $0 worth. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. Gurus may be added or dropped from the GuruFocus site at any time. Downloadable as a .pptx file. A hike is also under consideration for the voluntary scheme. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. Let us know if you like it and we may post more pieces with this option.) Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying Alfredo Naj Domingos prostate cancer was spreading. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Berkshire Hathaway BRK.B +0.31% 's future leaders, including Greg Abel, will be expected to put many of their financial eggs in the conglomerate's basket. Robert Flexon, President and CEO, Everyone has been so generous with us, sharing advice and stories, and we hope that what we do with the inn will come to reflect the spirit of this wonderful community.. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. The most active insiders traders include Capital Management, L.P.Ra , Capital Management, Llc Kol und Peter Kolchinsky. In . In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of $1.64B Fill in your details below or click an icon to log in: You are commenting using your WordPress.com account. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. In 2020, Novavax transformed from a $150 million biotech to an $8 billion vaccine developer. Nominations are now open for a special report that will highlight the contributions of LGBTQ+ biopharma leaders. Insider trading is most common in February, with the busiest year in 2023. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Right now, he is the most trending person in social media. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback Peter Kolchinsky's largest purchase order was 2,805,045 units , worth over Ben Ford was born and raised in Ames, Iowa. Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. . This . Gurus may be added or dropped from the GuruFocus site at any time. When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data In support of his arguments, he shared insights from government and industry professionals and cited facts and figures on the trajectory of the drug market. Peter Kolchinsky, Ph.D., has more than 18 years of experience in healthcare investing and is the founder of and a managing partner at RA Capital. Please note the magic link is October 20, 2021The vaccine business has long been a quiet and profitable game of kings. The higher rates are proposed to kick in on April 1. If you're already an Endpoints subscriber, enter your email below for a This investment adviser does not provide advice to individual investors. Well be posting shots of the different projects around the inn in the coming weeks, but first we thought you might like to know a little bit about us. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. Peter Kolchinsky - Insider Trading Tracker . I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order. Save my name, email, and website in this browser for the next time I comment. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. Things here have been busy; were working hard to get the inn ready for our June 2010 grand opening. A biotech analyst bets Novavax has the best data. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and These . Novartis can't make enough of it, Q&A with Christine Baeder, new chair of the generic industrys AAM, UK government plans to hike revenue clawback rates beginning in April, Merz Aesthetics hands the mic to Christina Aguilera in Botox rival campaign. Baeder explains below not only whats coming for AAM and its member generic drug companies, but also her thoughts on the Inflation Reduction Act and the new five-year FDA user fee deal. Your email address will not be published. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Warren Buffett has made it clear. Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. Anna is excited about introducing her dressage horse Jurist to the local network of trails. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Dr. Kolchinsky also leads RA Capitals engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. So they invited their close friends Keri and Ben up for what they expected to be a reality check. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. Want this in your inbox every Saturday morning? In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. There are 15 older and 2 younger executives at Wave Life Sciences. So they invited their close friends Keri and Ben up for what they, Keri and Ben, long-time city dwellers, were, new dream and a substantial life-style change, One of my favorite paintings is from the Blue Horses, , and, of course, horses were what brought the couple to Woodstock. Stock quotes provided by InterActive Data. Current Endpoints readerscan visit their reader profileto add Endpoints Weekly. Wishing you all the best of luck in your new endeavor. . Enjoy a 7-Day Free Trial Thru Mar 12, 2023! Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . $12.54M on September 23, 2020. It was simply awesome! It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. We'll e-mail you a link to set a new password. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. Fundamental company data provided by Morningstar, updated daily. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name Please note this link is one-time use only and is valid for only 24 hours. Peter Kolchinsky started RA Capital Management after completing his Ph.D. in virology from Harvard in 2001. He currently works with the State and Local Government Practice Group of the consulting firm Accenture. Refer a Friend and Earn One Month of Free Membership. The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . There are also venture partner and executive-in-residence programs to build up the bench. Carl Ashley Morris, Chief Scientific Officer, These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. "Stay tuned for more covid and science explainers. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves on the boards of publicly- and privately-held life science companies. Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation He currently manages a fund that invests in healthcare and biotechnology companies. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. magic link that lets you log in quickly without using a password. In a 2018 article, Eric Bender argued that cancer drugs aren't worth the price we pay for them and recommended legislative measures be taken to align prices with the values drugs provide. Shes currently earning her PhD in European History at Boston College. On average, Peter trades about 366,737 units every 19 days since 2014. Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. . $5M . He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. These were worth $145 million and represented 2% of its portfolio. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. I would love for [the Blue Horse Inn] to be the kind of place that a writer just starting on a novel escapes to for hospitality and inspiration, Keri said, adding that she hopes the new business still allows her some time for her own writing. Fundamental company data provided by Morningstar, updated daily. 2001 - Present22 years. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. Carl Ashley Morris who sold 441 units worth Change), You are commenting using your Facebook account. Covid-19. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. and bought an estimated value of $64.19M worth of shares. Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Blog at WordPress.com.RSS 2.0Comments RSS 2.0, The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. Verified account Protected Tweets @; Suggested users The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Executives behind AI and precision medicine startup Tempus are putting together another AI outfit in Chicago focused on oncology drug discovery and development. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by Come and visit me at the Pacific Water Conference, booth 520! In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Let us know who we should consider our main ask is that you make the nominations personal. Sign up here. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. See Peter Kolchinsky's compensation, career history, education, & memberships. Verified account Protected Tweets @ Protected Tweets @ The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. One of my favorite paintings is from the Blue Horses series by the German painter Franz Marc, Anna explained, and, of course, horses were what brought the couple to Woodstock in the first place. Managing Partner | RA Capital Management Peter is a founder and Managing Partner at RA Capital Management, active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. But, as it often does, chance overrode plan, and they both fell in love with the property on the first visit. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. GuruFocus.com is not operated by a broker or a dealer. "And another thread that speaks to need for insurance reform. Wallmine is a radically better financial terminal. out how to maintain the house themselves, from the roof to the, Anna and Keri hope their husbands dont electroc, can be found busily working at The Blue Horse Inn most weekends. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. But there was a lot of adjusting to do, for everyone in the family. Insider trading is most common in June, with the busiest year in 2022. Required fields are marked *. and Catherine James, EVP and General Counsel Boston, MA. . The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. To get here required a long and winding route. If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. worked in film production in Berlin for several years before returning to Boston, where she met Peter. Hbm Healthcare Investments Cayman Ltd who bought, In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. The most active traders at the company are The estimated Net Worth of Peter Kolchinsky is at least $96 million dollars as of 23 June 2020. , Keri said, adding that she hopes the new business still allows her some time for her own writing. The Entrepreneur's Guide to a Biotech Startup. Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. Franklin Resources Inc, Peter Kolchinsky, Ph.D. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Hard work has helped him rise to the top. Peter Kolchinsky owns about 1,311,247 units of Mineralys. https://t.co/y9IG2Z5txl" New to Endpoints? The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The two announced Monday morning that theyve put together their first pure-play venture fund at RA Capital Management, which has been known to bet on just about every angle in healthcare investing from rounds to follow-on investments at public companies. Anna maintains relationships with many people -- family . Internal digital and data science expertise is critical to developing a united value proposition that aligns the benefits of the digital and medicinal product. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! 2004-2023 GuruFocus.com, LLC. Keri is currently the Chair of the Religious Studies department at St. Pauls School for, Keri is also a writer and is currently working on a, through Annas participation at the GMHA dressage, Anna and Peter originally hoped to find a vacation home that, was big enough to share with friends and family, looked at the inn more out of curiosity than, they both fell in love with the property on the first visit, We loved the idea of having a second home that was also an inn, but. the community will feel welcome. He currently manages a fund that invests in healthcare and biotechnology companies. Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. Change), You are commenting using your Twitter account. Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. It was written by our very kind neighbor, Hasse K. Halley. Peter Kolchinsky is a biotechnology investor and a scientist. America is rightfully outraged when patients cant afford the medicines they need. In addition, they want to provide guests with ample opportunities to enjoy local arts, food, and activities and look forward to collaborating with local artists, craftsmen, and business owners to come up with interesting packages. But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. hope that what we do with the inn will come to reflect the spirit of this wonderful community. Come and visit me at the Pacific Water Conference, booth 520! In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of $9.83M The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. She received a Masters degree in TV production at Boston University and worked in film production in Berlin for several years before returning to Boston, where she met Peter. Welcome to the official Blue Horse Inn blog! The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. After serving in the US Air Force JAG Corps, Ben, at a private law firm and in Massachusetts, He currently works with the State and Local Government Practice Group of. Data from the new InnoLead/KPMG US He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. $12.69M on March 23, 2021. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Listed on the paperwork are Tempus CEO Eric Lefkofsky and operating chief Ryan Fukushima, who is described as CEO of Pathos. Health Care. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. December 22nd, 2014. . Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Come and visit me at the Pacific Water Conference, booth 520! These things have helped him get to where he is now one of the richest people on Earth. Ilan Ganot, Director, Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. Peter Kolchinsky: It has infected people in different parts of the world. Welcome back to Endpoints Weekly, your review of the weeks top biopharma headlines.